Case Study: Xspray Pharma improves bioavailability and reduces food interactions with Quotient Sciences Translational Pharmaceutics

Xspray Pharma reduces food interaction and speeds Phase I testing with Quotient Sciences

Xspray Pharma, a drug delivery company, faced the challenge of improving the bioavailability of a protein kinase inhibitor drug that suffered from poor solubility and significant food interactions. They partnered with Quotient Sciences and utilized its Translational Pharmaceutics® integrated approach to address this issue during their Phase I study.

Quotient Sciences enabled Xspray Pharma to rapidly return to the lab, alter the dose, transfer the new formulation to manufacturing, and resume clinical testing in a very short timeframe. This solution significantly accelerated the speed of their results and reduced their overall program timelines.

Xspray Pharma